Rima Al-awar
Direttore/Membro del Consiglio presso SATELLOS BIOSCIENCE INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Rima Al-awar is currently the Director at Satellos Bioscience, Inc. and has been a Member at Ontario Institute for Cancer Research since 2008.
She holds a doctorate degree from North Carolina State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 29/05/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Rima Al-awar
| Società | Posizione | Inizio |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Direttore/Membro del Consiglio | 05/12/2021 |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Rima Al-awar
| North Carolina State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
- Borsa valori
- Insiders
- Rima Al-awar
